Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Labarre is active.

Publication


Featured researches published by Michael Labarre.


Journal of Clinical Investigation | 2004

Novel APC-like properties of human NK cells directly regulate T cell activation

Jacob Hanna; Tsufit Gonen-Gross; Jonathan Fitchett; Tony Rowe; Mark Daniels; Tal I. Arnon; Roi Gazit; Aviva Joseph; Karoline W. Schjetne; Alexander Steinle; Angel Porgador; Dror Mevorach; Debra Goldman-Wohl; Simcha Yagel; Michael Labarre; Jane H. Buckner; Ofer Mandelboim

Initiation of the adaptive immune response is dependent on the priming of naive T cells by APCs. Proteomic analysis of unactivated and activated human NK cell membrane-enriched fractions demonstrated that activated NK cells can efficiently stimulate T cells, since they upregulate MHC class II molecules and multiple ligands for TCR costimulatory molecules. Furthermore, by manipulating antigen administration, we show that NK cells possess multiple independent unique pathways for antigen uptake. These results highlight NK cell-mediated cytotoxicity and specific ligand recognition by cell surface-activating receptors on NK cells as unique mechanisms for antigen capturing and presentation. In addition, we analyzed the T cell-activating potential of human NK cells derived from different clinical conditions, such as inflamed tonsils and noninfected and CMV-infected uterine decidual samples, and from transporter-associated processing antigen 2-deficient patients. This in vivo analysis revealed that proinflammatory, but not immune-suppressive, microenvironmental requirements can selectively dictate upregulation of T cell-activating molecules on NK cells. Taken together, these observations offer new and unexpected insights into the direct interactions between NK and T cells and suggest novel APC-like activating functions for human NK cells.


Journal of Biological Chemistry | 2006

An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor FcϵRIα

Stephen J. Demarest; Jennifer Hopp; Julie Chung; Karen Hathaway; Elisabeth Mertsching; Xianjun Cao; Judy George; Konrad Miatkowski; Michael Labarre; Michael Shields; Marilyn R. Kehry

The interaction between IgE-Fc (Fcϵ) and its high affinity receptor FcϵRI on the surface of mast cells and basophils is a key event in allergen-induced allergic inflammation. Recently, several therapeutic strategies have been developed based on this interaction, and some include Fcϵ-containing moieties. Unlike well characterized IgG therapeutics, the stability and folding properties of IgE are not well understood. Here, we present comparative biophysical analyses of the pH stability and thermostability of Fcϵ and IgG1-Fc (Fcγ). Fcϵ was found to be significantly less stable than Fcγ under all pH and NaCl conditions tested. Additionally, the Cϵ3Cϵ4 domains of Fcϵ were shown to become intrinsically unfolded at pH values below 5.0. The interaction between Fcϵ and an Fcγ-FcϵRIα fusion protein was studied between pH 4.5 and 7.4 using circular dichroism and a combination of differential scanning calorimetry and isothermal titration calorimetry. Under neutral pH conditions, the apparent affinity of Fcϵ for the dimeric fusion protein was extremely high compared with published values for the monomeric receptor (KD < 10-12 m). Titration to pH 6.0 did not significantly change the binding affinity, and titration to pH 5.5 only modestly attenuated affinity. At pH values below 5.0, the receptor binding domains of Fcϵ unfolded, and interaction of Fcϵ with the Fcγ-FcϵRIα fusion protein was abrogated. The unusual pH sensitivity of Fcϵ may play a role in antigen-dependent regulation of receptor-bound, non-circulating IgE.


Biotechnology and Bioengineering | 2001

Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII

Julian Davies; LiYing Jiang; Li-Zhen Pan; Michael Labarre; Darrell R Anderson; Mitchell E Reff


Archive | 2000

Production of tetravalent antibodies

Gary R. Braslawsky; Nabil Hanna; Kandasamy Hariharan; Michael Labarre; Tri B. Huynh


Archive | 2003

Buffered formulations for concentrating antibodies and methods of use thereof

Tzung-Horng Yang; Michael J. Bacica; Michael Labarre


International Journal of Immunopharmacology | 2000

In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain.

Takehiko Nakamura; William S. Kloetzer; Peter Brams; Kandasamy Hariharan; Soulaima Chamat; Xianjun Cao; Michael Labarre; Paul Chinn; Ron Morena; William S. Shestowsky; Yan-Ping Li; Agnes Chen; Mitchell Reff


Archive | 2000

Radiolabeling kit and binding assay

Paul Chinn; Ronald Morena; Michael Labarre; John E. Leonard


Molecular Immunology | 2005

Proteomic analysis of human natural killer cells: insights on new potential NK immune functions.

Jacob Hanna; Jonathan Fitchett; Tony Rowe; Mark Daniels; Melissa Heller; Tsufit Gonen-Gross; Efrat Manaster; Samuel Y. Cho; Michael Labarre; Ofer Mandelboim


Archive | 2000

Regioselective synthesis of DTPA derivatives

Paul Chinn; Albert Gyorkos; Michael Labarre; Steve Ruhl; Thomas Ryskamp


Archive | 2006

Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors

Jonathon Fitchett; Mark Daniels; Michael Labarre; Karen Mclachlan; Tony Rowe; Nicole W. O'brien; Samuel Y. Cho; Melissa Heller

Collaboration


Dive into the Michael Labarre's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nabil Hanna

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge